Exacerbation of pathology by oxidative stress in respiratory and locomotor muscles with Duchenne muscular dystrophy.
about
Diaphragm Muscle Adaptation to Sustained Hypoxia: Lessons from Animal Models with Relevance to High Altitude and Chronic Respiratory DiseasesNutraceuticals and Their Potential to Treat Duchenne Muscular Dystrophy: Separating the Credible from the ConjecturePharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trialsAltered cross-bridge properties in skeletal muscle dystrophiesRimmed vacuoles in Becker muscular dystrophy have similar features with inclusion myopathies.Autophagy is Impaired in the Tibialis Anterior of Dystrophin Null MiceRestoration of the dystrophin-associated glycoprotein complex after exon skipping therapy in Duchenne muscular dystrophyPerspectives on: SGP symposium on mitochondrial physiology and medicine: mitochondrial superoxide flashes: from discovery to new controversiesEmerging drugs for Duchenne muscular dystrophyFunctional classification of skeletal muscle networks. II. Applications to pathophysiology.Axial stretch-dependent cation entry in dystrophic cardiomyopathy: Involvement of several TRPs channelsInhibition of iPLA2 β and of stretch-activated channels by doxorubicin alters dystrophic muscle function.Wasting mechanisms in muscular dystrophy.Oxidative stress in muscular dystrophy: from generic evidence to specific sources and targets.Characterization of reactive oxygen species in diaphragm.Sialic acid deficiency is associated with oxidative stress leading to muscle atrophy and weakness in GNE myopathy.Dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein.Clostridium perfringens phospholipase C induced ROS production and cytotoxicity require PKC, MEK1 and NFκB activationRanolazine promotes muscle differentiation and reduces oxidative stress in C2C12 skeletal muscle cells.Fast skeletal myofibers of mdx mouse, model of Duchenne muscular dystrophy, express connexin hemichannels that lead to apoptosis.Oxidative stress, NF-κB and the ubiquitin proteasomal pathway in the pathology of calpainopathy.Tempol Supplementation Restores Diaphragm Force and Metabolic Enzyme Activities in mdx Mice.Neurotrophins, cytokines, oxidative parameters and funcionality in Progressive Muscular Dystrophies.Drug Repurposing for Duchenne Muscular Dystrophy: The Monoamine Oxidase B Inhibitor Safinamide Ameliorates the Pathological Phenotype in Mice and in Myogenic Cultures From DMD Patients
P2860
Q28066535-20375997-A764-47C3-BC9D-D5424A0ADBB1Q28072269-6210C3CD-4AAB-44FC-B376-A707650C6B6BQ34152280-863E0081-B124-4B7A-8857-EDCC1F264EB7Q34335939-53DBC302-A7E4-43BE-B116-8F8ADFD3DEC6Q34517484-24D40BD4-23E1-4E95-AB37-368A515B8123Q35057217-3D986551-C010-4774-8F71-736C35223327Q35750055-2BA2ABB7-2A8B-498D-8617-D07F87253122Q35995750-9F8A36CB-3561-4CE0-AB3F-506F4C9F7D10Q36363716-502B91AE-9EED-4471-9878-4416AF10C58DQ36530917-D9EA3882-532C-4D31-BECC-B1023811BCA2Q36834928-41C2AFF6-2F97-4756-8F1A-C03DA423B825Q37046769-1E4FA327-5500-4368-A07E-639B2B4B9016Q37138490-AE09F0F9-E6DB-4D34-ADCA-F61D4734E556Q38195206-0DE60E30-C7CD-4349-80CA-991BD36BC18FQ38261430-CDE9A5D5-726A-454D-8302-2D021E9E1641Q38785817-2BA491CD-13B9-4742-8AB8-C7F44EF7B5BAQ41282592-1169AE67-30C1-4706-8B6F-42A5840B67D9Q41888502-6B07D4E8-9AB3-413F-8AB3-65C95D81B46CQ42362305-EF69BDC6-FE53-4FC8-A352-26C0F88FBD7DQ42488015-52821451-6B81-43FA-A59C-C3B6342C66D6Q46262861-EABEE6F5-0930-430E-A82A-C6C5B3EA3F9EQ47100974-A4243463-5BF5-4467-987E-E49560207631Q48211845-603536A4-28DC-488E-9C7E-E7BF603E05ADQ58781307-CE5BF923-9963-43B3-A734-7DA0C6C77784
P2860
Exacerbation of pathology by oxidative stress in respiratory and locomotor muscles with Duchenne muscular dystrophy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Exacerbation of pathology by o ...... h Duchenne muscular dystrophy.
@en
Exacerbation of pathology by o ...... h Duchenne muscular dystrophy.
@nl
type
label
Exacerbation of pathology by o ...... h Duchenne muscular dystrophy.
@en
Exacerbation of pathology by o ...... h Duchenne muscular dystrophy.
@nl
prefLabel
Exacerbation of pathology by o ...... h Duchenne muscular dystrophy.
@en
Exacerbation of pathology by o ...... h Duchenne muscular dystrophy.
@nl
P2860
P1476
Exacerbation of pathology by o ...... h Duchenne muscular dystrophy.
@en
P2093
John M Lawler
P2860
P304
P356
10.1113/JPHYSIOL.2011.207456
P407
P577
2011-03-08T00:00:00Z